Skip to main content
SpringerLink
Log in

Signals for fetal and neonatal ADRs after in-utero biologics exposure

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Dernoncourt A, et al. Fetal and Neonatal Adverse Drug Reactions Associated with Biologics Taken During Pregnancy by Women with Autoimmune Diseases: Insights from an Analysis of the World Health Organization Pharmacovigilance Database (VigiBase?) BioDrugs : 22 Nov 2022. Available from: URL: https://doi.org/10.1007/s40259-022-00564-4

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Signals for fetal and neonatal ADRs after in-utero biologics exposure. Reactions Weekly 1934, 11 (2022). https://doi.org/10.1007/s40278-022-28392-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-28392-9

Search

Navigation